L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 5 drugs in this drug class and its subclasses.
- 5 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
-
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
- L01EH01 Lapatinib 1 drug
- L01EH02 Neratinib 1 drug
- L01EH03 Tucatinib 1 drug
- L01EH04 Zongertinib 1 drug
- L01EH06 Sevabertinib 1 drug
-
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Lapatinib (lapatinib ditosylate) 1 drug
- Neratinib (neratinib maleate) 1 drug
- Sevabertinib 1 drug
- Tucatinib 1 drug
- Zongertinib 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Hernexeos PM (L01EH04 Zongertinib) | prescription (Rx) |
| Hyrnuo (L01EH06 Sevabertinib) | prescription (Rx) |
| Nerlynx (L01EH02 Neratinib) | prescription (Rx) |
| Tukysa PM (L01EH03 Tucatinib) | prescription (Rx) |
| Tykerb (L01EH01 Lapatinib) | prescription (Rx) |
Other classes of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
- L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
- L01EX Other protein kinase inhibitors 30 drugs
Other names of the drug class
- English (United Kingdom): L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
- German: L01EH Humaner epidermaler Wachstumsfaktor-Rezeptor 2 (HER2)-Tyrosinkinase-Inhibitoren
- German (Austria): L01EH Humaner epidermaler Wachstumsfaktor-Rezeptor 2 (HER2)-Tyrosinkinase-Inhibitoren
- Italian: L01EH Inibitoritirodsina chinasi recett. 2 Fattore crescita EPD. (HER2)
- Turkish: L01EH İnsan epidermal büyüme faktörü reseptörü 2 (HER2) tirozin kinaz inhibitörleri
- Slovak: L01EH Inhibítory receptora humánneho epidermálneho rastového faktora 2 (HER2) tyrozínkinázy
- German (Switzerland): L01EH Humaner epidermaler Wachstumsfaktor-Rezeptor 2 (HER2)-Tyrosinkinase-Inhibitoren
- Italian (Switzerland): L01EH Inibitoritirodsina chinasi recett. 2 Fattore crescita EPD. (HER2)
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EH
Ask your doctor or pharmacist for advice.